Findings demonstrate MoCA predicts treatment dropout in substance use disorders, suggesting its value in monitoring cognitive impairment.
Findings indicate MoCA as a practical screening tool for early detection of cognitive impairment, longitudinal monitoring and personalised treatment planning in SUD.
No takes yet. Share an insight, caveat, or question.
Requena-Ocaña et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: